Cochrane Abstracts
Oral versus intravenous fluoropyrimidines for colorectal cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Versus Intravenous Fluoropyrimidines for Colorectal Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Oral_versus_intravenous_fluoropyrimidines_for_colorectal_cancer. Accessed 03 October 2023.
Oral versus intravenous fluoropyrimidines for colorectal cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Oral_versus_intravenous_fluoropyrimidines_for_colorectal_cancer. Accessed October 3, 2023.
Oral versus intravenous fluoropyrimidines for colorectal cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Oral_versus_intravenous_fluoropyrimidines_for_colorectal_cancer
Oral Versus Intravenous Fluoropyrimidines for Colorectal Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 October 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Oral_versus_intravenous_fluoropyrimidines_for_colorectal_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral versus intravenous fluoropyrimidines for colorectal cancer
ID - 434871
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Oral_versus_intravenous_fluoropyrimidines_for_colorectal_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -
